Agarwal R - Search Results

1

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.

Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G; FIDELIO-DKD Investigators. Bakris GL, et al. Among authors: agarwal r. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. N Engl J Med. 2020. PMID: 33264825 Free article. Clinical Trial.

2

Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers.

Agarwal R, Toto RD. Agarwal R, et al. Am J Kidney Dis. 1993 Aug;22(2):296-9. doi: 10.1016/s0272-6386(12)70321-9. Am J Kidney Dis. 1993. PMID: 8352256

3

ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. VAL-K Study Group.

Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, Agarwal R, Catanzaro D. Bakris GL, et al. Among authors: agarwal r. Kidney Int. 2000 Nov;58(5):2084-92. doi: 10.1111/j.1523-1755.2000.00381.x. Kidney Int. 2000. PMID: 11044229 Free article. Clinical Trial.

4

Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.

Panesar A, Agarwal R. Panesar A, et al. Among authors: agarwal r. Am J Kidney Dis. 2002 Nov;40(5):924-31. doi: 10.1053/ajkd.2002.36322. Am J Kidney Dis. 2002. PMID: 12407636

5

Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade.

Agarwal R. Agarwal R. Am J Physiol Renal Physiol. 2003 Apr;284(4):F863-9. doi: 10.1152/ajprenal.00385.2002. Epub 2002 Dec 27. Am J Physiol Renal Physiol. 2003. PMID: 12505865 Free article. Clinical Trial.

6

Etiology and management of hypertension in chronic kidney disease.

Andersen MJ, Agarwal R. Andersen MJ, et al. Among authors: agarwal r. Med Clin North Am. 2005 May;89(3):525-47. doi: 10.1016/j.mcna.2004.12.001. Med Clin North Am. 2005. PMID: 15755466 Review.

7

Correlates of systolic hypertension in patients with chronic kidney disease.

Agarwal R, Andersen MJ. Agarwal R, et al. Hypertension. 2005 Sep;46(3):514-20. doi: 10.1161/01.HYP.0000178102.85718.66. Epub 2005 Aug 15. Hypertension. 2005. PMID: 16103271

8

Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D. Agarwal R, et al. Kidney Int. 2005 Dec;68(6):2823-8. doi: 10.1111/j.1523-1755.2005.00755.x. Kidney Int. 2005. PMID: 16316359 Free article. Clinical Trial.

9

Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease.

Agarwal R, Andersen MJ. Agarwal R, et al. Kidney Int. 2006 Apr;69(7):1175-80. doi: 10.1038/sj.ki.5000247. Kidney Int. 2006. PMID: 16467785 Free article.

10

A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD.

Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N. Schulman G, et al. Among authors: agarwal r. Am J Kidney Dis. 2006 Apr;47(4):565-77. doi: 10.1053/j.ajkd.2005.12.036. Am J Kidney Dis. 2006. PMID: 16564934 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,245 results

Search Page

Filters